← Scoopfeeds — Intelligent news, curated.
Hims Sales Miss on Rising Competition for Weight-Loss Drugs
business

Hims Sales Miss on Rising Competition for Weight-Loss Drugs

Bloomberg Markets · May 11, 2026, 8:28 PM · Also reported by 2 other sources

Hims & Hers Health Inc. reported a first-quarter loss and sales that missed Wall Street estimates amid increasing competition in the weight-loss drug market.

Read full story on Bloomberg Markets → More top stories

Also covered by

Healthline Weight Loss Surgeries Decline as GLP-1 Use Skyrockets. Why This Matters Investing.com Hims & Hers reports surprise loss in Q1, shares dive after hours

More in business

Investing.com
Form 13D/A Atara Biotherapeutics For: 11 May
Investing.com
Form 144 LIQUIDITY SERVICES INC For: 11 May
Investing.com
Form 144 MACOM TECHNOLOGY SOLUTIONS HOLDINGS For: 11 May
Investing.com
Form 144 Skyward Specialty Insurance For: 11 May
Investing.com
Form 144 MOLINA HEALTHCARE For: 11 May
Aggregated and edited by the Scoop newsroom. We surface news from Bloomberg Markets alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop